Balcom J H, Keck T, Warshaw A L, Antoniu B, Graeme-Cook F, Fernández-del Castillo C
Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
Ann Surg. 2001 Sep;234(3):344-50; discussion 350-1. doi: 10.1097/00000658-200109000-00008.
To determine the presence of telomerase activity in a variety of periampullary malignancies and pancreatic diseases and quantify its activity to establish any association with the stage or aggressiveness of malignancy.
Progressive shortening of telomeres, repetitive DNA sequences at the ends of chromosomes, plays a role in cell senescence. Telomerase catalyzes conservation of telomeric repeats and may promote cell immortality and hence malignancy. It is absent in normal tissues but upregulated in more than 80% of cancers.
Fresh specimens of 62 periampullary tumors were snap-frozen in liquid nitrogen and adjacent tissue was formalin-fixed for histopathology. The telomerase repeat amplification protocol (TRAP) was used to obtain telomerase DNA products. These were separated with gel electrophoresis, stained with SYBR green, and quantified by densitometry. Findings were confirmed with a fluorometric TRAP assay in which fluorescent primers specific for telomerase were selectively amplified in its presence.
Telomerase activity was upregulated in 26 of 33 periampullary malignancies (79%): 17 of 21 pancreatic adenocarcinomas (81%), 2 of 2 cholangiocarcinomas, 2 of 2 duodenal carcinomas, and 5 of 8 ampullary carcinomas (63%). Poorly differentiated periampullary tumors had significantly higher telomerase activity than well-differentiated tumors, and tumors larger than 2 cm had significantly higher telomerase activity than those 2 cm or smaller. Pancreatic ductal adenocarcinomas with lymph node metastases had significantly greater activity than node-negative cancers. Two of 11 intraductal papillary mucinous tumors were positive for telomerase activity, but only in foci of invasive carcinoma. Chronic pancreatitis (n = 7), serous cystadenomas (n = 5), benign mucinous cystic neoplasms (n = 4), neuroendocrine cancer (n = 1), and acinar cell carcinoma (n = 1) had no detectable telomerase activity.
Telomerase activity is common in periampullary carcinomas. The magnitude of activity correlates with aggressiveness in pancreatic adenocarcinoma and may prove useful as a molecular index for biologic staging.
确定多种壶腹周围恶性肿瘤及胰腺疾病中端粒酶活性的存在情况,并对其活性进行定量,以确定其与恶性肿瘤分期或侵袭性之间的任何关联。
端粒是染色体末端的重复DNA序列,其逐渐缩短在细胞衰老中起作用。端粒酶催化端粒重复序列的保守性,可能促进细胞永生化,从而导致恶性肿瘤。它在正常组织中不存在,但在80%以上的癌症中上调。
将62例壶腹周围肿瘤的新鲜标本在液氮中速冻,相邻组织用福尔马林固定用于组织病理学检查。采用端粒酶重复序列扩增法(TRAP)获得端粒酶DNA产物。通过凝胶电泳分离这些产物,用SYBR green染色,并通过光密度法进行定量。结果通过荧光TRAP分析得到证实,在该分析中,端粒酶特异性荧光引物在其存在时被选择性扩增。
33例壶腹周围恶性肿瘤中有26例(79%)端粒酶活性上调:21例胰腺腺癌中有17例(81%),2例胆管癌,2例十二指肠癌,8例壶腹癌中有5例(63%)。低分化壶腹周围肿瘤的端粒酶活性明显高于高分化肿瘤,直径大于2 cm的肿瘤端粒酶活性明显高于直径2 cm或更小的肿瘤。有淋巴结转移的胰腺导管腺癌的活性明显高于无淋巴结转移的癌症。11例导管内乳头状黏液性肿瘤中有2例端粒酶活性阳性,但仅在浸润癌灶中。7例慢性胰腺炎、5例浆液性囊腺瘤、4例良性黏液性囊性肿瘤、1例神经内分泌癌和1例腺泡细胞癌未检测到端粒酶活性。
端粒酶活性在壶腹周围癌中常见。活性强度与胰腺腺癌的侵袭性相关,可能作为生物学分期的分子指标。